Evidence map›Paper›PMID 27906159›Full record

ArticleNature2016

Persistent microbiome alterations modulate the rate of post-dieting weight regain.

Christoph A Thaiss, Shlomik Itav, Daphna Rothschild, Mariska T Meijer, Maayan Levy, Claudia Moresi, Lenka Dohnalová, Sofia Braverman, Shachar Rozin, Sergey Malitsky and 10 more

4 registry-linked trialsAbstract read
PubMed Publisher
In one paragraph

Article in Nature, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 243 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
243citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05002153 naunknown statusnot on this mapstarted 2022, after this paper: background citation

The Role of Microbiome in Recurrent Obesity

TypeinterventionalSponsorAssaf Harofeh MCRan2022 to 2024Enrolled300ConditionsObesity, Weight Loss, FMTArmsFecal microbiota transplantation (FMT), Placebo
NCT05329571 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Microbiome Correlates of Dietary Interventions in Patients With Fibromyalgia and Their Association With Symptom Modification

TypeinterventionalSponsorMcGill University Health Centre/Research Institute of the McGill University Health CentreRan2021 to 2024Enrolled50ConditionsFibromyalgia, Diet, Gluten-FreeArmsLow-FODMAP diet, Gluten-free Diet, Control group
NCT05603403 phase4completednot on this mapstarted 2022, after this paper: background citation

Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial Placebo-Controlled Clinical Trial To Evaluate The Efficacy And Safety Of Probiatop In The Treatment Of Digestive Symptoms

TypeinterventionalSponsorAzidus BrasilRan2022 to 2023Enrolled150ConditionsSigns and Symptoms, DigestiveArmsProbiatop, Placebo
NCT06657001 enrolling by invitationnot on this mapstarted 2025, after this paper: background citation

Enabling Microbiomics- Driven Personalized Nutrition (EMPOWER)

Typeobservational_patient_registrySponsorMayo ClinicRan2025 to 2028Enrolled4,001ConditionsInflammatory Bowel Disease (IBD), Irritable Bowel Syndrome (IBS), Celiac Disease, Diarrhea
3 · Its place in the literature

Who cites it

243 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Roles of the gut microbiome in weight management.Nature reviews. Microbiology · 2023
    Pooled it
  3. Pooled it
  4. Testosterone administration partially modulates gut microbiota responses to severe energy deficit.American journal of physiology. Endocrinology and metabolism · 2026
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

183 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Christoph A ThaissImmunology Department, Weizmann Institute of Science, 76100 Rehovot, Israel.
Shlomik ItavImmunology Department, Weizmann Institute of Science, 76100 Rehovot, Israel.
Daphna RothschildDepartment of Computer Science and Applied Mathematics, Weizmann Institute of Science, 76100 Rehovot, Israel.
Mariska T MeijerImmunology Department, Weizmann Institute of Science, 76100 Rehovot, Israel.
Maayan LevyImmunology Department, Weizmann Institute of Science, 76100 Rehovot, Israel.
Claudia MoresiImmunology Department, Weizmann Institute of Science, 76100 Rehovot, Israel.
Lenka DohnalováImmunology Department, Weizmann Institute of Science, 76100 Rehovot, Israel.
Sofia BravermanImmunology Department, Weizmann Institute of Science, 76100 Rehovot, Israel.
Shachar RozinImmunology Department, Weizmann Institute of Science, 76100 Rehovot, Israel.
Sergey MalitskyDepartment of Plant and Environmental Sciences, Weizmann Institute of Science, 76100 Rehovot, Israel.
Mally Dori-BachashImmunology Department, Weizmann Institute of Science, 76100 Rehovot, Israel.
Yael KupermanDepartment of Veterinary Resources, Weizmann Institute of Science, 76100 Rehovot, Israel.
Inbal BitonDepartment of Veterinary Resources, Weizmann Institute of Science, 76100 Rehovot, Israel.
Arieh GertlerThe Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University, Rehovot 76100, Israel.
Alon HarmelinDepartment of Veterinary Resources, Weizmann Institute of Science, 76100 Rehovot, Israel.
Hagit ShapiroImmunology Department, Weizmann Institute of Science, 76100 Rehovot, Israel.
Zamir HalpernResearch Center for Digestive Tract and Liver Diseases, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, 69978 Tel Aviv, Israel.
Asaph AharoniDepartment of Plant and Environmental Sciences, Weizmann Institute of Science, 76100 Rehovot, Israel.
Eran SegalDepartment of Computer Science and Applied Mathematics, Weizmann Institute of Science, 76100 Rehovot, Israel.
Eran ElinavImmunology Department, Weizmann Institute of Science, 76100 Rehovot, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In tackling the obesity pandemic, considerable efforts are devoted to the development of effective weight reduction strategies, yet many dieting individuals fail to maintain a long-term weight reduction, and instead undergo excessive weight regain cycles. The mechanisms driving recurrent post-dieting obesity remain largely elusive. Here we identify an intestinal microbiome signature that persists after successful dieting of obese mice and contributes to faster weight regain and metabolic aberrations upon re-exposure to obesity-promoting conditions. Faecal transfer experiments show that the accelerated weight regain phenotype can be transmitted to germ-free mice. We develop a machine-learning algorithm that enables personalized microbiome-based prediction of the extent of post-dieting weight regain. Additionally, we find that the microbiome contributes to diminished post-dieting flavonoid levels and reduced energy expenditure, and demonstrate that flavonoid-based 'post-biotic' intervention ameliorates excessive secondary weight gain. Together, our data highlight a possible microbiome contribution to accelerated post-dieting weight regain, and suggest that microbiome-targeting approaches may help to diagnose and treat this common disorder.

Identifiers

PMID27906159

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.